» Articles » PMID: 35131002

Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction

Overview
Journal Oncol Res
Specialty Oncology
Date 2022 Feb 8
PMID 35131002
Authors
Affiliations
Soon will be listed here.
Abstract

This study was directed to deepen the effects of nutrient shortage on BCR/Abl expression and signaling in chronic myeloid leukemia (CML) cells. The backbone of the study was cell culture in medium lacking glucose, the consumption of which we had previously shown to drive BCR/Abl suppression, and glutamine, the other main nutrient besides glucose. In this context, we focused on the role of lactate, the main by-product of glucose metabolism under conditions of rapid cell growth, in particular as a modulator of the maintenance of CML stem/progenitor cell potential, a crucial determinant of disease course and relapse of disease. The results obtained indicated that lactate is a powerful surrogate of glucose to prevent the suppression of BCR/Abl signaling and is therefore capable to maintain BCR/Abl-dependent CML stem/progenitor cell potential. A number of metabolism-related functional and phenotypical features of CML cells were also determined. Among these, we focused on the effect of lactate on oxygen consumption rate, the dependence of this effect on the cell surface lactate carrier MCT-1, and the relationship of the lactate effect to pyruvate and to the activity of mitochondrial pyruvate carrier.

Citing Articles

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies.

Jedlicka M, Feglarova T, Janstova L, Hortova-Kohoutkova M, Fric J Front Immunol. 2022; 13:932055.

PMID: 36330529 PMC: 9623302. DOI: 10.3389/fimmu.2022.932055.

References
1.
Ding J, Karp J, Emadi A . Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomark. 2017; 19(4):353-363. DOI: 10.3233/CBM-160336. View

2.
Zhang H, Li H, Xi H, Li S . HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells. Blood. 2012; 119(11):2595-607. PMC: 3311277. DOI: 10.1182/blood-2011-10-387381. View

3.
Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005; 5(3):172-83. DOI: 10.1038/nrc1567. View

4.
Rovida E, Peppicelli S, Bono S, Bianchini F, Tusa I, Cheloni G . The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. Cell Cycle. 2014; 13(20):3169-75. PMC: 4612663. DOI: 10.4161/15384101.2014.964107. View

5.
Cheloni G, Tanturli M . The Culture Repopulation Ability (CRA) Assay and Incubation in Low Oxygen to Test Antileukemic Drugs on Imatinib-Resistant CML Stem-Like Cells. Methods Mol Biol. 2016; 1465:73-85. DOI: 10.1007/978-1-4939-4011-0_7. View